Monte Rosa Therapeutics, Inc. Common Stock
GLUE
GLUE: Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates.
moreShow GLUE Financials
Recent trades of GLUE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GLUE's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on GLUE's company Twitter account
Number of mentions of GLUE in WallStreetBets Daily Discussion
Recent insights relating to GLUE
Recent picks made for GLUE stock on CNBC
ETFs with the largest estimated holdings in GLUE
Flights by private jets registered to GLUE